Article ID Journal Published Year Pages File Type
4198113 Health Policy 2011 11 Pages PDF
Abstract
Further removals from the list of reimbursable drugs should take into account the possibility of negative impact on public health and potential savings.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Public Health and Health Policy
Preview
Analysis of the impact of removing mucolytics and expectorants from the list of reimbursable drugs on prescription rates: A time-series analysis for France 1998-2010
Authors
, , ,